Toggle Main Menu Toggle Search

Open Access padlockePrints

Categorising visual hallucinations in early Parkinson's disease

Lookup NU author(s): Benjamin Clegg, Dr Gordon Duncan, Dr Tien Kheng Khoo, Professor David Burn, Professor Alison Yarnall, Dr Rachael LawsonORCiD



© 2018 - IOS Press and the authors. All rights reserved. Background: Visual hallucinations (VHs) are common in Parkinson's disease (PD), with prevalence ranging from 27-50% in cross-sectional cohorts of patients with well-established disease. However, minor hallucinations may occur earlier in the disease process than has been previously reported. Objective: We sought to categorise VHs in a cohort of newly diagnosed PD patients and establish their relationship to other clinical features. Methods: Newly diagnosed PD participants (n = 154) were recruited as part of the Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation in PD (ICICLE-PD) study. Participants completed the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS III), Montreal Cognitive Assessment (MoCA) and Parkinson's Disease Questionnaire (PDQ-39) to assess motor severity, cognition and quality of life (QoL), respectively. VHs were classified using the North East Visual Hallucinations Inventory. Hierarchical regression was used to build predictive models of motor severity, QoL and cognition. Results: 22% (n = 34) of participants experienced recurrent VHs with minor VHs being most frequently reported (64.7% of hallucinators). Complex VHs were present in 32.4% of hallucinating participants. Linear regression showed VHs predicted poorer PDQ-39 and MoCA scores (β= 0.201, p = 0.006 and β= - 0.167, p = 0.01, respectively) but not motor severity (p > 0.05). Conclusions: Over a fifth of people with newly diagnosed PD reported recurrent VHs; minor hallucinations were the most common, although a small proportion reported complex VHs. Recurrent VHs were found to be a significant independent predictor of cognitive function and QoL but not motor severity. Our findings highlight the importance of screening for VHs at diagnosis.

Publication metadata

Author(s): Clegg BJ, Duncan GW, Khoo TK, Barker RA, Burn DJ, Yarnall AJ, Lawson RA

Publication type: Article

Publication status: Published

Journal: Journal of Parkinson's Disease

Year: 2018

Volume: 8

Issue: 3

Pages: 447-453

Online publication date: 14/08/2018

Acceptance date: 18/06/2018

Date deposited: 28/06/2018

ISSN (print): 1877-7171

ISSN (electronic): 1877-718X

Publisher: IOS Press


DOI: 10.3233/JPD-181338


Altmetrics provided by Altmetric